Mercer Global Advisors
COCH icon

Mercer Global Advisors’s Envoy Medical COCH Stock Holding History

Mercer Global Advisors’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.6K Buy
+5,808
New +$3.94K ﹤0.01% 5378

Other funds holding COCH

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Mercer Global Advisors's COCH Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Envoy Medical (COCH) in Q2 2026: 5,808 shares worth $4.6K. The stake represents ﹤0.01% of the portfolio and ranks #5378 among its holdings.

24 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Mercer Global Advisors held 5,808 shares of Envoy Medical worth $4.6K as of Q2 2026.
  • Envoy Medical was a new Mercer Global Advisors position in Q2 2026.
  • Envoy Medical made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5378 holding.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.